MORROW GEORGE J — SEC insider filings
SEC reporting owner CIK 1068754. 23 insider filings on record with FilingPulse; latest filed 2026-11-03.
Transaction summary — filings shown
Covers all 23 filings on record, filed 2020-10-28 to 2026-11-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 30 legs across 7 filings — 115,000 shares, $34,690,055 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 42.
- Largest priced transaction: sale of 10,983 shares @ $466.85 ($5,127,434) in ALIGN TECHNOLOGY INC, filed 2020-10-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ALIGN TECHNOLOGY INC (ALGN) | Director | 12 | — | 15 legs · 45,000 sh · $24,626,851 | 18 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | Director | 11 | — | 15 legs · 70,000 sh · $10,063,204 | 24 |
Insider filings — MORROW GEORGE J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-03 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 300 @ $53.64 · Sale (S): 300 @ $149 · Option exercise (M): 7,500 @ $53.64 · Sale (S): 1,900 @ $144.98 · Sale (S): 4,300 @ $145.86 · Sale (S): 1,300 @ $146.76 · +12 more | EDGAR |
| 2026-05-29 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 2,567 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | ALIGN TECHNOLOGY INC (ALGN) | Option exercise (M): 1,745 @ $0 · Option exercise (M): 1,745 (derivative) @ $0 | EDGAR |
| 2026-05-21 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 3,318 @ $0 · Option exercise (M): 3,318 (derivative) @ $0 | EDGAR |
| 2025-11-26 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 15,000 @ $47.89 · Sale (S): 15,000 @ $143.37 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 2,869 @ $0 · Grant/award (A): 3,318 (derivative) @ $0 · Option exercise (M): 2,869 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | ALIGN TECHNOLOGY INC (ALGN) | Option exercise (M): 1,148 @ $0 · Option exercise (M): 1,148 (derivative) @ $0 · Grant/award (A): 1,745 (derivative) @ $0 | EDGAR |
| 2024-05-24 | 4 | ALIGN TECHNOLOGY INC (ALGN) | Grant/award (A): 1,148 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 2,869 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 4,199 @ $0 · Option exercise (M): 4,199 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | ALIGN TECHNOLOGY INC (ALGN) | Option exercise (M): 1,029 @ $0 · Option exercise (M): 1,029 (derivative) @ $0 | EDGAR |
| 2024-03-15 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 20,000 @ $39.79 · Sale (S): 20,000 @ $139.42 · Option exercise (M): 20,000 @ $39.79 · Sale (S): 20,000 @ $139.41 · Option exercise (M): 20,000 (derivative) @ $39.79 · Option exercise (M): 20,000 (derivative) @ $39.79 | EDGAR |
| 2023-05-31 | 4 | ALIGN TECHNOLOGY INC (ALGN) | Gift (G): 10,000 @ $0 | EDGAR |
| 2023-05-19 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 4,199 (derivative) @ $0 | EDGAR |
| 2023-05-19 | 4 | ALIGN TECHNOLOGY INC (ALGN) | Option exercise (M): 1,114 @ $0 · Option exercise (M): 1,114 (derivative) @ $0 · Grant/award (A): 1,029 (derivative) @ $0 | EDGAR |
| 2022-05-20 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 9,724 (derivative) @ $0 | EDGAR |
| 2022-05-19 | 4 | ALIGN TECHNOLOGY INC (ALGN) | Option exercise (M): 524 @ $0 · Option exercise (M): 524 (derivative) @ $0 · Grant/award (A): 1,114 (derivative) @ $0 | EDGAR |
| 2021-08-03 | 4 | ALIGN TECHNOLOGY INC (ALGN) | Sale (S): 1,500 @ $705.74 · Sale (S): 3,248 @ $707.95 · Sale (S): 252 @ $708.93 | EDGAR |
| 2021-05-21 | 4 | ALIGN TECHNOLOGY INC (ALGN) | Option exercise (M): 1,271 @ $0 · Option exercise (M): 1,271 (derivative) @ $0 · Grant/award (A): 524 (derivative) @ $0 | EDGAR |
| 2021-05-20 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 8,833 (derivative) @ $0 | EDGAR |
| 2021-02-08 | 4 | ALIGN TECHNOLOGY INC (ALGN) | Sale (S): 4,798 @ $622.19 · Sale (S): 1,101 @ $622.98 · Sale (S): 507 @ $623.92 · Sale (S): 3,657 @ $625.02 · Sale (S): 3,337 @ $626.71 · Sale (S): 1,121 @ $627.46 · +1 more | EDGAR |
| 2020-11-04 | 4 | ALIGN TECHNOLOGY INC (ALGN) | Sale (S): 5,000 @ $480.03 | EDGAR |
| 2020-10-28 | 4 | ALIGN TECHNOLOGY INC (ALGN) | Sale (S): 1,485 @ $460.39 · Sale (S): 4,805 @ $464.43 · Sale (S): 10,983 @ $466.85 · Sale (S): 2,727 @ $468.78 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-27 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1068754 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs